Previous studies had indicated that renal epidermal growth factor receptors (EGFRs) were activated in models of diabetic nephropathy (DN), and inhibition of EGFR activity protected against progressive DN in T1 DM and T2 DM [43]. The gene discussed is EGFR; the disease is liver dysplastic nodule.